Adam Mossoff on the Orange Book and Pharma Patents
ICLE Affiliate Adam Mossoff was quoted in a Bloomberg Law piece about the effects of a US Court of Appeals for the Federal Circuit ruling on drugmaker patents:
The 1984 Hatch-Waxman Act created the system that governs how brand-name drugs and their generic competitors are approved and litigated in the US. The Federal Circuit’s ruling and FTC crackdown threaten to undermine that regulatory framework, which helped turn the US generics market into a pharmaceuticals powerhouse, said Adam Mossoff, an IP law professor at George Mason University.
“An entire multi-billion-dollar industry was created entirely on the basis of the Orange Book,” Mossoff said. In the four decades since the law’s passage, he said, the sector has grown to “hundreds of billions in market capital” from “a mere couple hundred million.”
Read the full piece here.